Medicus Pharma Ltd (MDCX)

Feb 12, 2026

Medicus Pharma cleared to launch Phase 2b Teverelix study in Prostate Cancer - Proactive financial news

Feb 12, 2026

Feb 12, 2026

Medicus Pharma Partners With Gorlin Syndrome Alliance to Expand Access to SKINJECT - MSN

Feb 12, 2026

Feb 12, 2026

Medicus Pharma on Bloomberg World - Corsicana Daily Sun

Feb 12, 2026

Feb 11, 2026

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - PhillyBurbs

Feb 11, 2026

Feb 11, 2026

FDA clears Medicus Pharma’s prostate cancer drug for phase 2b trial By Investing.com - Investing.com South Africa

Feb 11, 2026

Feb 10, 2026

FDA clears Medicus Pharma’s prostate cancer drug for phase 2b trial - Investing.com Nigeria

Feb 10, 2026

Feb 10, 2026

New to The Street Signs Six-Part Media Series Featuring Medicus Pharma Ltd. - USA Today

Feb 10, 2026

Feb 10, 2026

Small cap wrap: Medicus Pharma, 1911 Gold, NanoViricides, Nextech3D.ai, NextSource Materials… - Proactive financial news

Feb 10, 2026

Feb 10, 2026

Medicus Pharma Wins FDA Go-Ahead for Phase 2b Teverelix Trial in High-Risk Prostate Cancer - TipRanks

Feb 10, 2026

Feb 10, 2026

Medicus Pharma receives FDA clearance to proceed with Phase 2b prostate cancer study - Proactive financial news

Feb 10, 2026

Feb 10, 2026

Medicus Pharma Receives FDA 'Study May Proceed” Clearance For Teverelix® Phase 2b Study in Advanced Prostate Cancer Patients with High Cardiovascular Risk - The Manila Times

Feb 10, 2026

Feb 10, 2026

FDA clears trial of Teverelix for prostate cancer with high heart risk - Stock Titan

Feb 10, 2026

Feb 09, 2026

How Medicus Pharma Ltd. Equity Warrant stock reacts to inflationary pressures2025 Support & Resistance & Momentum Based Trading Ideas - mfd.ru

Feb 09, 2026

Feb 09, 2026

Trade Report: Can Medicus Pharma Ltd expand its profit marginsJuly 2025 Review & Risk Managed Trade Strategies - baoquankhu1.vn

Feb 09, 2026

Feb 04, 2026

Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform - The Marion Star

Feb 04, 2026

Feb 03, 2026

Merger Talk: Can Medicus Pharma Ltd expand its profit marginsTrade Entry Summary & Consistent Profit Focused Trading Strategies - baoquankhu1.vn

Feb 03, 2026

Feb 02, 2026

Medicus Pharma Reports Q3 Loss Amid Strategic Growth - MSN

Feb 02, 2026

Feb 02, 2026

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Canton Repository

Feb 02, 2026